WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007002264) BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/002264    International Application No.:    PCT/US2006/024269
Publication Date: 04.01.2007 International Filing Date: 21.06.2006
IPC:
G01N 33/50 (2006.01), G01N 33/574 (2006.01)
Applicants: THE JOHNS HOPKINS UNIVERSITY [US/US]; 3400 N. Charles Street, Baltimore, MD 21218 (US) (For All Designated States Except US).
CIPHERGEN BIOSYSTEMS, INC. [US/US]; 6611 Dumbarton Circle, Fremont, CA 94555 (US) (For All Designated States Except US).
ZHANG, Zhen [CN/US]; (US) (For US Only).
CHAN, Daniel, W. [US/US]; (US) (For US Only).
FUNG, Eric, Thomas [US/US]; (US) (For US Only).
WANG, Zheng [CN/US]; (US) (For US Only).
ZHANG, Fujun [CN/US]; (US) (For US Only)
Inventors: ZHANG, Zhen; (US).
CHAN, Daniel, W.; (US).
FUNG, Eric, Thomas; (US).
WANG, Zheng; (US).
ZHANG, Fujun; (US)
Agent: CORLESS, Peter, F.; EDWARDS ANGELL PALMER & DODGE LLP, P.o. Box 55874, Boston, MA 02205 (US)
Priority Data:
60/693,324 22.06.2005 US
Title (EN) BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS
(FR) BIO-MARQUEUR POUR CANCER OVARIEN : PROTÉINES APPARENTÉES À CTAP3
Abstract: front page image
(EN)The present invention provides a protein-based biomarker that is useful in qualifying ovarian cancer status in a patient. In particular, the biomarker of this invention is useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarker can be detected by SELDI mass spectrometry.
(FR)La présente invention concerne un bio-marqueur à base de protéine utile pour qualifier l'état d'un cancer ovarien chez une patiente. En particulier, le bio-marqueur de la présente invention sert à classer un échantillon sujet en tant que cancer ovarien ou cancer non ovarien. Le bio-marqueur peut être détecté par spectrométrie de masse SELDI.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)